Pre-Open Stock Movers 06/14: (RAPT) (CRSR) (RIOT) Higher; (ATXI) (RIDE) (RACE) Lower (more...)
- Indexes close up more than 1% as investors assess Fed news
- China Tells Local Authorities to Prepare For a 'Possible Storm' and Prevent Unrest as Evergrande Crisis Unravels - WSJ
- Salesforce (CRM) Raises FY22 Revenue Guidance; Initiates FY23 Revenue
- Oil prices rise, hit 2-month highs on supply worries
- IDFA Seen as a 'Real Headwind' for Facebook (FB) but Analysts Remain Positive
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Pre-Open Stock Movers:
RAPT Therapeutics (NASDAQ: RAPT) 89% HIGHER; announced positive topline results from its randomized placebo-controlled Phase 1b clinical trial of RPT193 as monotherapy in 31 patients with moderate-to-severe atopic dermatitis (AD).
Avenue Therapeutics, Inc. (NASDAQ: ATXI) 49.4% LOWER; announced that it has received a second Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application seeking approval for IV tramadol.
Corsair Gaming, Inc. (NASDAQ: CRSR) 28% HIGHER; gains on high social media activity
Lordstown Motors Corp. (NASDAQ: RIDE) 17.8% LOWER; reported the results of the investigation by the Special Committee of its Board of Directors regarding the Hindenburg Research short report published in March. CEO and CFO resigns.
Riot Blockchain (NASDAQ: RIOT) 9.7% HIGHER; Bitcoin-related stocks gained Monday as the cryptocurrency rose back above $40,000
Terns Pharmaceuticals, Inc. (Nasdaq: TERN) 9% HIGHER; reported positive top-line results from the Phase 2a LIFT clinical trial of TERN-101, a liver-distributed farnesoid X receptor (FXR) agonist for the treatment of patients with NASH.
Marathon Digital Holdings (NASDAQ: MARA) 8.7% HIGHER; Bitcoin-related stocks gained Monday as the cryptocurrency rose back above $40,000
Novavax, Inc. (Nasdaq: NVAX) 6.5% HIGHER; today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial. The study enrolled 29,960 participants across 119 sites in the U.S. and Mexico to evaluate efficacy, safety and immunogenicity, with an emphasis on recruiting a representative population of communities and demographic groups most impacted by the disease.
Bit Digital (NASDAQ: BTBT) 6.3% HIGHER; Bitcoin-related stocks gained Monday as the cryptocurrency rose back above $40,000
Microstrategy, Inc. (NASDAQ: MSTR) 5% HIGHER; Bitcoin-related stocks gained Monday as the cryptocurrency rose back above $40,000
Ferrari NV (NYSE: RACE) 3.7% LOWER; Goldman Sachs downgraded from Buy to Sell with a price target of EUR170.00 (from EUR192.00).
Coinbase (NASDAQ: COIN) 2.5% HIGHER; Bitcoin-related stocks gained Monday as the cryptocurrency rose back above $40,000
Squarespace (NYSE: SQSP) 1.7% HIGHER; new Wall Street coverage leans positive.
Wendy's (NASDAQ: WEN) 1.6% HIGHER; Northcoast Research upgraded from Neutral to Buy with a price target of $30.00.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 09/23: (CDOR) (BB) (JOBY) Higher; (EAR) (SYBX) (SCS) Lower (more...)
- Amplitude Healthcare Acquisition (AMHC) Climbs 80% Pre-Open
- Eargo (EAR) Stock is Down 56% in After Hours. Here's Why
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesGoldman Sachs, Pre-Open Losers, Pre-Open Winners, Bitcoin, Pre Market Movers, Hindenburg Research
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!